1) La descarga del recurso depende de la página de origen
2) Para poder descargar el recurso, es necesario ser usuario registrado en Universia


Detalles del recurso

Descripción

Recent high-profile reports have reignited an interest in acetate metabolism in cancer. Acetyl-CoA synthetases that catalyse the conversion of acetate to acetyl-CoA have now been implicated in the growth of hepatocellular carcinoma, glioblastoma, breast cancer and prostate cancer. In this Review, we discuss how acetate functions as a nutritional source for tumours and as a regulator of cancer cell stress, and how preventing its (re)capture by cancer cells may provide an opportunity for therapeutic intervention.

Pertenece a

Enlighten  

Autor(es)

Schug, Zachary T. -  Vande Voorde, Johan -  Gottlieb, Eyal - 

Id.: 69789651

Versión: 1.0

Estado: Final

Tipo de recurso: Articles  -  PeerReviewed  - 

Tipo de Interactividad: Expositivo

Nivel de Interactividad: muy bajo

Audiencia: Estudiante  -  Profesor  -  Autor  - 

Estructura: Atomic

Coste: no

Copyright: sí

Requerimientos técnicos:  Browser: Any - 

Relación: [References] http://eprints.gla.ac.uk/139817/
[References] 10.1038/nrc.2016.87

Fecha de contribución: 08-nov-2017

Contacto:

Localización:
* Schug, Z. T., Vande Voorde, J. and Gottlieb, E. (2016) The metabolic fate of acetate in cancer. Nature Reviews Cancer , 16(11), pp. 708-717. (doi:10.1038/nrc.2016.87 ) (PMID:27562461)

Otros recursos del mismo autor(es)

  1. Proteome-wide analysis of cysteine oxidation reveals metabolic sensitivity to redox stress Reactive oxygen species (ROS) are increasingly recognised as important signalling molecules through ...
  2. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 International audience
  3. Auto-commentary on: “Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells” We have recently uncovered an abnormal increase in mitochondrial oxidative metabolism in therapy-res...
  4. Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells Treatment of chronic myeloid leukemia (CML) with imatinib mesylate and other second- and/or third-ge...
  5. PDE2A2 regulates mitochondria morphology and apoptotic cell death via local modulation of cAMP/PKA signalling cAMP/PKA signalling is compartmentalised with tight spatial and temporal control of signal propagati...

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.